Day Zero Diagnostics
0 followers
The future of infectious disease diagnostics starts at Day Zero. By using whole-genome sequencing (WGS) and the proprietary enabling technologies, Day Zero is creating a new class of sequencing-based in-vitro diagnostics that generates clinically actionable data at scale.
Org chart
Jong Lee
President & CEO, Co-founder
Jong Lee
Collapse
Miriam Huntley
CTO & Co-founder
Doug Kwon
CSO & Co-Founder
Melis Anahtar
Scientific Co-founder
Dougal Maclaurin
Scientific Co-founder
Dekel Gelbman
SVP, Business Development & Strategy
Rene Robert
VP, Product Realization
Melodie Domurad
VP, Medical Affairs
Manoj Nair
Vice President, Molecular Assay Development
Melis Anahtar, MD, PhD
Co-Founder
